Latest Health & pharmaceuticals news

4th October
U.S. federal appeals court reinstates GSK’s £182 million ruling against Teva Pharmaceutical
1st October
Smith & Nephew forecasts a 4% decline in third-quarter underlying revenue
28th September
What health stocks are in play post-U.S. election?
25th September
Endo International to manufacture Novavax’s candidate COVID-19 vaccine
23rd September
Allergy Therapeutics reports a 6% annualised growth in revenue in fiscal 2020
22nd September
Aurora Cannabis reports £20.42 million of adjusted EBITDA loss in Q4
21st September
Illumina expresses plans of acquiring Grail Inc. for £6.25 billion
18th September
Roche says its Actemra drug reduces the severity of COVID-19 in hospitalised patients
17th September
Oxford Biomedica reports a 6% annualised growth in H1 revenue
14th September
Gilead Sciences to buy Immunomedics Inc for £16.32 billion
14th September
AstraZeneca to resume its late-stage clinical trial of the experimental COVID-19 vaccine
9th September
AstraZeneca halts late-stage trial for its candidate COVID-19 vaccine
7th September
Dechra Pharmaceuticals’ annual operating profit jumps 33.6%
1st September
AstraZeneca starts late-stage clinical trial for its candidate COVID-19 vaccine in the U.S.
26th August
Teva’s U.S. business indicted, shares gain anyways
26th August
Elekta’s core profit margin jumps to 18.5% in the fiscal first quarter
25th August
AstraZeneca stock price gains as Trump considers fast-tracking their COVID-19 vaccine
24th August
Blackstone to acquire Takeda Pharmaceutical’s consumer healthcare business
17th August
Sanofi to acquire U.S. Principia Biopharma Inc. for £2.82 billion
10th August
Canopy Growth’s revenue comes in 22% higher in the fiscal Q1
7th August
Hikma Pharmaceuticals’ revenue jumps 8% in the fiscal first half
6th August
Novo Nordisk reports £1.28 billion of net profit in the second quarter
5th August
CVS Health tops analysts’ estimates for earnings and revenue in Q2
5th August
Moderna’s revenue jumps over 400% in the fiscal second quarter
4th August
Bayer stock price slips after reporting a Q2 loss of $11.2 billion
1 2 3 4 5 6 7 8 9 10 57
Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.